title: Vancomycin use in pediatric hematology-oncology patients.
abstract: Across-sectional study was performed of pediatric hematology-oncology patients who received vancomycin; use was compared to the Centers for Disease Control and Prevention (CDC) recommendations for vancomycin use. Thirty-seven patients received 308 doses of vancomycin. AR patients initially received vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations.
authors.affiliation: Hospital Infections Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Georgia 30333, USA.
authors.forename: H A
authors.initials: HA
authors.lastname: Hopkins
authors.forename: R L
authors.initials: RL
authors.lastname: Sinkowitz-Cochran
authors.forename: B A
authors.initials: BA
authors.lastname: Rudin
authors.forename: H L
authors.initials: HL
authors.lastname: Keyserling
authors.forename: W R
authors.initials: WR
authors.lastname: Jarvis
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D017723:Drug Utilization Review; D005260:Female; D005845:Georgia; D019983:Guideline Adherence; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D017053:Infection Control / Q000592:standards; D008297:Male; D016522:Oncology Service, Hospital / Q000592:standards*; D017410:Practice Guidelines as Topic; D014640:Vancomycin / Q000627:therapeutic use*; D020713:Vancomycin Resistance
chemical_list: D014640:Vancomycin